Investment
Features
FeesSafety
Academy
More
Pluang+

$16.6B in Bitcoin and Ethereum options expire Sept 25, signaling bullish bets ahead.

Market News
14 Sep 2026
Crypto Briefing
View Source
Bullish
$16.6B in Bitcoin and Ethereum options expire Sept 25, signaling bullish bets ahead.

About $16.6 billion worth of Bitcoin and Ethereum options on Deribit are set to expire on September 25, 2026, with Bitcoin options making up $14.63 billion and Ethereum $1.93 billion. The options show a strong call bias, indicating traders expect prices to rise beyond current levels near $78,000 for Bitcoin. The max pain price, where most options expire worthless, is between $72,000 and $75,000, below current prices. Market makers' hedging around this expiry could drive price movements, making the days leading to September 25 critical to watch for shifts in put/call ratios and volatility.

The story on Bitcoin and Ethereum options expiring in Q3 2026 provides context for cryptocurrency market activity. For readers following major cryptocurrencies on Pluang, 27 out of 50 rose and 22 fell as of September 15, 2026, 04:51 WIB. Notable movers include AVAX at Rp134.969 with a 3.20% increase and a typical hold time of 86 days, THETA at Rp3.479 down 3.12%, and CAKE at Rp41.849 up 2.94%.

More News

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

BNP Paribas lowered Hormel Foods' price target from $26 to $23, indicating a potential 16.2% upside from its current price of around $19.80. Despite a 50.5% decline in its share price over five years, Hormel Foods remains attractive for dividend inve...

Analyst Insights
Neutral
1 hour ago
Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays initiated coverage of Becton, Dickinson and Company (BDX) with an "Underweight" rating, indicating a cautious outlook for the medical technology stock. BDX is partnering with the U.S. government to boost domestic manufacturing and strengthen...

Market News
Bearish
1 hour ago
Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley increased its price target for Eli Lilly to $1,430 from $1,419, maintaining an Overweight rating. This new target implies a potential upside of about 20.8% from the current share price of around $1,184. The adjustment reflects updated ...

Analyst Insights
Bullish
2 hours ago
Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher expects about 6% organic growth in Q3, driven by strong client retention and new business despite easing property insurance pricing. Cantor Fitzgerald lowered its price target to $280, below the $288 average from 19 analysts who m...

Analyst Insights
Bullish
3 hours ago
Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Needham raised Zscaler's price target to $255, citing strong demand for AI-related cybersecurity solutions. Zscaler aims to exceed $8 billion in annual recurring revenue by fiscal 2031, driven by increasing needs to protect against AI-powered cyberat...

Analyst Insights
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App